332.9000 -15.60 (-4.48%)
NSE Apr 04, 2025 15:31 PM
Volume: 286.1K
 

332.90
-4.48%
Axis Direct
We expect revenue and PAT CAGR of 13.3% and 12.3% respectively over the period FY21-FY23E and recommend BUY with TP of Rs 760.
Aarti Drugs Ltd. is trading below all available SMAs
More from Aarti Drugs Ltd.
All earning calls
Investor presentations from Aarti Drugs Ltd.
All investor presentations